Washington Trust CO Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Washington Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$99.73 - $148.48 $64,824 - $96,512	-650 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$65.78 - $105.02 $19,734 - $31,506	-300 Reduced 31.58%	650 $63,000
Q1 2021 Apr 28, 2021	BUY	$64.07 - $91.75 $35,238 - $50,462	550 Added 137.5%	950 $65,000
Q3 2020 Nov 05, 2020	BUY	$59.04 - $77.95 $23,616 - $31,180	400 New	400 $26,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.